Skip to main content

Table 1 Patient characteristics

From: Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

Characteristic

Number of patients (n = 16)

Sex

 Male

10 (62.5 %)

 Female

6 (37.5 %)

Age (years)

 Median (range)

61 (43–77)

ECOG-PS

 0

3 (18.8 %)

 1

10 (62.5 %)

 2

3 (18.8 %)

Smoking status

 Never smoker

4 (25.0 %)

 Ex-smoker

12 (75.0 %)

Pack-yearsa

 Median (range)

45.5 (17–124)

Clinical stage

 IIIA

2 (12.5 %)

 IV

4 (25.0 %)

 Recurrence

10 (62.5 %)

Diagnostic procedure

 Surgery

10 (62.5 %)

 CT-NB

3 (18.8 %)

 Autopsy

3 (18.8 %)

Pathological features

 Epithelial component

  Adenocarcinoma

7 (43.8 %)

  Squamous cell carcinoma

2 (12.5 %)

  Adenosquamous carcinoma

1 (6.3 %)

  Large cell carcinoma

4 (25.0 %)

  NOS

2 (12.5 %)

 Sarcomatoid component

  Spindle cell

0 (0.0 %)

  Giant cell

2 (12.5 %)

  Spindle cell and giant cell

14 (62.5 %)

  1. CT-NB CT-guided needle biopsy, NOS not otherwise specified
  2. aEx-smoker (n = 12)